The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,265,618 in first-year total cost, median $2,468,281.
Most frequent study sections
- Special Emphasis Panel[ZCA1 GRB-S (A1)]3
- Special Emphasis Panel[ZCA1 RPRB-7 (A1)]2
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL1
- MAYO CLINIC ARIZONA1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- SLOAN-KETTERING INST CAN RESEARCH1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center1U54CA224079-01 | SAWYERS, CHARLES L. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,585,894 | ZCA1 |
| 2017 | An integrated translational approach to overcome drug resistance1U54CA224068-01 | CORCORAN, RYAN BRUCEFLAHERTY, KEITH T | MASSACHUSETTS GENERAL HOSPITAL, MA | $2,500,407 | ZCA1 |
| 2017 | Overcoming Drug Resistance in Multiple Myeloma1U54CA224018-01 | STEWART, ALEXANDER KEITH | MAYO CLINIC ARIZONA, AZ | $2,468,281 | ZCA1 |
| 2017 | Bay Area Team Against Resistance1U54CA224081-01 | BIVONA, TREVER GKUO, CALVIN J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,401,042 | ZCA1 |
| 2017 | Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML1U54CA224019-01 | DRUKER, BRIAN JTYNER, JEFFREY WALLACE | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $2,309,994 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.